For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Score ...

Investors interested in stocks from the Medical Services sector have probably already heard of HealthEquity (HQY) and Medpace (MEDP) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Sty ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end. However, it's pretty easy to find cutting-edge growth stocks w ...

HealthEquity (HQY) closed the last trading session at $76.24, gaining 7.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $104.14 indicates a 36.6% upside potential. The average comprises 14 short-term price targets ranging from a low of $92 to a high of $115, with a standard deviation of $6.14. While the lowest estimate indicates an increase of 20.7% from the current price level, ...

HealthEquity (HQY) recently announced a new collaboration with Paytient, a healthcare technology firm, to offer working professionals greater confidence in pursuing healthcare through Health Payment Accounts (HPAs). This new partnership is likely to enhance working professionals' access to healthcare. HPAs offer a no-interest, no-fee option for employees to pursue medical care with flexible payment terms. As a result of the partnership, a lot of employees are likely to onboard HQY's platform where they can ...

HealthEquity, Inc. (HQY) reported adjusted earnings per share (EPS) of 86 cents for second-quarter fiscal 2025, surpassing the Zacks Consensus Estimate by 22.9%. The bottom line improved 62.2% on a year-overyear basis. GAAP EPS in the fiscal second quarter was 40 cents, up 233% from the year-ago quarter's EPS of 12 cents. Shares of HQY were up 0.2% in after-market trading following the earnings call. HealthEquity Revenues in Detail In the fiscal second quarter, the company generated revenues of $299.93 mill ...

HealthEquity (HQY) reported $299.93 million in revenue for the quarter ended July 2024, representing a yearover-year increase of 23.2%. EPS of $0.86 for the same period compares to $0.53 a year ago. The reported revenue represents a surprise of +5.43% over the Zacks Consensus Estimate of $284.48 million. With the consensus EPS estimate being $0.70, the EPS surprise was +22.86%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall St ...

HealthEquity (HQY) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.53 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 22.86%. A quarter ago, it was expected that this provider of services for managing health care accounts would post earnings of $0.66 per share when it actually produced earnings of $0.80, delivering a surprise of 21.2 ...

Highlights of the second quarter include: Revenue of $299.9 million, an increase of 23% compared to $243.5 million in Q2 FY24. Net income of $35.8 million, compared to $10.6 million in Q2 FY24, with non-GAAP net income of $76.3 million, an increase of 67% compared to $45.6 million in Q2 FY24. Net income per diluted share of $0.40, compared to $0.12 in Q2 FY24, with non-GAAP net income per diluted share of $0.86, compared to $0.53 in Q2 FY24. Adjusted EBITDA of $128.3 million, an increase of 46% compared to ...

Wall Street analysts forecast that HealthEquity (HQY) will report quarterly earnings of $0.70 per share in its upcoming release, pointing to a year-over-year increase of 32.1%. It is anticipated that revenues will amount to $284.48 million, exhibiting an increase of 16.8% compared to the year-ago quarter. The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial ...